These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A comparison of buspirone, diazepam, and placebo in patients with chronic anxiety states. Olajide D; Lader M J Clin Psychopharmacol; 1987 Jun; 7(3):148-52. PubMed ID: 2885344 [TBL] [Abstract][Full Text] [Related]
24. Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study. Razavi D; Kormoss N; Collard A; Farvacques C; Delvaux N J Int Med Res; 1999; 27(6):264-72. PubMed ID: 10726235 [TBL] [Abstract][Full Text] [Related]
26. Treating anxiety while minimizing abuse and dependence. Sussman N J Clin Psychiatry; 1993 May; 54 Suppl():44-51. PubMed ID: 8099577 [TBL] [Abstract][Full Text] [Related]
27. Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Goa KL; Ward A Drugs; 1986 Aug; 32(2):114-29. PubMed ID: 2874976 [TBL] [Abstract][Full Text] [Related]
29. Patient acceptance as a factor in the effectiveness of treatment: an open assessment of potassium clorazepate ('Tranxene') and lorazepam in anxiety. Harris PG Curr Med Res Opin; 1974-1975; 2(10):664-8. PubMed ID: 4156290 [TBL] [Abstract][Full Text] [Related]
30. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study. Fontaine R; Beaudry P; Beauclair L; Chouinard G Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):189-97. PubMed ID: 2888159 [TBL] [Abstract][Full Text] [Related]
31. [Cloxazolam in dermatology. Double-blind study against dipotassium clorazepate]. Desmons F; Bergoend H; Thomas P; Piette F Lille Med; 1980; 25(1-2):45-8. PubMed ID: 6103494 [No Abstract] [Full Text] [Related]
32. A double-blind comparison of prazepam with diazepam, chlorazepate dipotassium and placebo in anxious out-patients. Fabre LF; McLendon DM; Mallette A J Int Med Res; 1979; 7(2):147-51. PubMed ID: 39012 [TBL] [Abstract][Full Text] [Related]
33. Buspirone: an anxioselective alternative for the management of anxiety disorders. Riblet LA; Eison AS; Eison MS; Newton RE; Taylor DP; Temple DL Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):663-8. PubMed ID: 6364236 [TBL] [Abstract][Full Text] [Related]
34. [The chlorazepate test in anxiety-depressive states]. Peyre F; Bourgeois M Ann Med Psychol (Paris); 1988; 146(7):655-62. PubMed ID: 2906229 [No Abstract] [Full Text] [Related]
35. The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Goldberg HL; Finnerty RJ Am J Psychiatry; 1979 Sep; 136(9):1184-7. PubMed ID: 382878 [TBL] [Abstract][Full Text] [Related]
36. Buspirone, Parkinson's disease, and the locus ceruleus. Ludwig CL; Weinberger DR; Bruno G; Gillespie M; Bakker K; LeWitt PA; Chase TN Clin Neuropharmacol; 1986; 9(4):373-8. PubMed ID: 2873889 [TBL] [Abstract][Full Text] [Related]
37. "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic". Uhlenhuth EH J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):109-16. PubMed ID: 6130067 [TBL] [Abstract][Full Text] [Related]
39. [Anxiolysis, sedation, and stress reduction following oral premedication with midazolam in adults. A comparison with dipotassium clorazepate and placebo]. Berendes E; Scherer R; Rotthove K; Prien T Anaesthesist; 1996 Jun; 45(6):506-11. PubMed ID: 8767563 [TBL] [Abstract][Full Text] [Related]